The TGF-β signaling system, with its complexity and interactions with other cell signaling pathways via TGF-β receptors (TβRs) (64), demands further clarification of its actions and mechanisms to aid in developing effective clinical treatments for IPF. The gene discussed is TGFB1; the disease is idiopathic interstitial pneumonia.